Paracetamol (acetaminophen) for acute episodic tension‐type headache in adults
References
Additional references
MacGregor EA, Steiner TJ, Davies PTG, for the British Association for the Study of Headache. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension‐type, cluster, and medication overuse headache. 3rd edition (1st revision). September 2010. Available at: http://217.174.249.183/upload/NS_BASH/2010_BASH_Guidelines.pdf. Accessed 6 September 2011.
Bendsten L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. EFNS guideline on the treatment of tension‐type headache ‐ report of an EFNS taskforce. European Journal of Neurology 2010;17(11):1318‐25. [PUBMED: 20482606]
Brainin M, Barnes M, Baron JC, Gilhus NE, Hughes R, Selmaj K, et al. for the Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces‐revised recommendations 2004. European Journal of Neurology 2004;11(9):577‐81. [PUBMED: 15379736]
National Library of Medicine. ClinicalTrials.gov. http://www.nlm.nih.gov. Accessed on 4th December 2010.
Edmeads J, Findlay H, Tugwell P, Pryse‐Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension‐type headache on life‐style, consulting behaviour, and medication use: a Canadian population survey. Canadian Journal of Neurological Sciences 1993;20(2):131‐7. [PUBMED: 8334575]
Forward SP, McGrath PJ, MacKinnon D, Brown TL, Swann J, Currie EL. Medication patterns of recurrent headache sufferers: a community study. Cephalalgia 1998;18(3):146‐51. [PUBMED: 9595208]
Fumal A, Schoenen J. Tension‐type headache: current research and clinical management. Lancet Neurolgy 2008;7(1):70‐83. [PUBMED: 18093564]
Graham GG, Scott KF. Mechanism of action of paracetamol. American Journal of Therapeutics 2005;12(1):46‐55.
Green MW. Primary and secondary headaches. In: Rowland LP, Pedley TA editor(s). Merritt's Neurology. 12th Edition. Philadelphia: Lippincott Williams and Wilkins, 2009:951‐60.
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
World Health Organization. International Clinical Trials Registy Platform Search Portal. http://apps.who.int/trialsearch/ (accessed 1 September 2010).
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:1‐160.
Bendtsen L, Bigal ME, Cerbo R, Diener HC, Holroyd K, Lampl C, et al. on behalf of the International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in tension‐type headache: second edition. Cephalalgia 2010;30(1):1‐16. [DOI: 10.1111/j.1468‐2982.2009.01948.x]
Kernick D, Stapley S, Hamilton W. GPs' classification of headache: is primary headache underdiagnosed?. British Journal of General Practice 2008;58(547):102‐4. [PUBMED: 18307854]
Lavados PM, Tenhamm E. Epidemiology of tension‐type headache in Santiago, Chile: a prevalence study. Cephalalgia 1998;18(8):552‐8. [Art. No.: 82.1998.DOI: 10.1046/j.1468‐2982.1998.1808552.x; PUBMED: 9827247]
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Mannix LK. Epidemiology and impact of primary headache disorders. Medical Clinics of North America 2001;85(4):887‐95. [DOI: 10.1016/S0025‐7125(05)70349‐7; PUBMED: 11480263]
Monteith TS, Sprenger T. Tension type headache in adolescence and childhood: where are we now?. Curr Pain Headache Rep 2010;14(6):424‐30. [PUBMED: 20927610]]
Pini LA, Del Bene E, Zanchin G, Sarchielli P, Di Trapani G, Prudenzano MP, et al. Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension‐type headache: a randomised, double‐blind, double‐dummy, cross‐over study versus placebo and naproxen sodium. Journal of Headache and Pain 2008;9(6):367‐73.
Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tension‐type headache. A randomized, double‐blind, placebo‐controlled trial. Cephalalgia 2002;22(9):740‐8.
Rasmussen BK. Epidemiology of headache. Cephalalgia 2001;21(7):774‐7. [PUBMED: 11595011]
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Roberts LJ, Morrow JD. Analgesic‐anitpyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman J G, Limbird LE, Gilman AG editor(s). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th Edition. New York: McGraw‐Hill, 2001:687‐732.
Russell MB. Tension‐type headache in 40‐year‐olds: a Danish population‐based sample of 4000. Journal of Headache and Pain 2005;6(6):441‐7. [PUBMED: 16388338]
Schachtel BP, Furey SA, Thoden WR. Nonprescription ibuprofen and acetaminophen in the treatment of tension‐type headache. Journal of Clinical Pharmacology 1996;36(12):1120‐5. [PUBMED: 9013368]
Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension‐type headache. JAMA 1998;279(5):381‐3. [PUBMED: 9459472]
Steiner TJ, Lange R. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension‐type headache: double‐blind placebo‐controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998;18(1):38‐43. [PUBMED: 9601623]
Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension‐type headache: placebo‐controlled dose‐ranging comparison with paracetamol. Cephalalgia 2003;23(1):59‐66. [PUBMED: 12534583]
Steiner TJ. Lifting the burden: the global campaign against headache. Lancet Neurology 2004;3(4):204‐5. [PUBMED: 15039030]
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher AI, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27(3):193‐210. [PUBMED: 17381554]
Anonymous. Analgesics, anti‐inflammatory drugs and antipyretics: paracetamol. In: Sweetman SC editor(s). Martindale: The Complete Drug Reference. 4th Edition. London: Pharmaceutical Press, 2005:76‐9.
Verhagen AP, Damen L, Berger MY, Passchier J, Merlin V, Koes BW. Is any one analgesic superior for episodic tension‐type headache?. Journal of Family Practice 2006;55(12):1064‐72. [PUBMED: 17137543]
World Health Organization. WHO model list of essential medicines. 15th edition. March 2007. www.who.int/medicines/publications/essentialmedicines/en/index.html (accessed 1 September 2010).
